Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2025-12-24 @ 4:13 PM
NCT ID:
NCT02853266
Eligibility Criteria:
Inclusion Criteria:
* History of KD before the age of 18, with or without macroscopic coronary lesions in the childhood phase. (KD group only)
* 18 years old or older at the time of the study.
* Agree on participating to all explorations of the study.
* Accept genotyping.
* Absence of cardiovascular risk factors
Exclusion Criteria:
* \- Atypical KD (KD group only)
* Documented or suspected coronary ischemia,
* Refusal to participate to the study or sign the consent
* Contra-indication to the injection of iodinated contrast agents (allergy, renal failure)
* Hypersensitivity to dobutamine,
* No effective contraception method for females with child bearing potential,
* Breastfeeding, or pregnant females,
* Treatment modifying endothelial reactivity
* History of severe intolerance to iodinated contrast agents,
* Subjects who can't hold their breath for at least 20 seconds,
* Irregular or absence of sinus rhythm, especially atrial or ventricular arrhythmia
* Unability to give information to the subject,
* No coverage from a Social Security system
* Deprivation of civil rights
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02853266
Study Brief:
Protocol Section:
NCT02853266